Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes.: Part III.: Apigenin, baicalelin, kaempherol, luteolin and quercetin
Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes.: Part III.: Apigenin, baicalelin, kaempherol, luteolin and quercetin
复制标题
DOI:
10.1002/ptr.1462
复制
发表时间:
2004-07-01
影响因子:
7.2
通讯作者:
Simánek, V
中科院分区:
文献类型:
--
作者:
Psotová, J;Chlopcíková, S;Simánek, V
Flavonoids are found universally in plants and act as free radical scavenging and chelating agents with anti-inflammatory, antiischemic, vasodilating and chemoprotective properties. In this study, the antilipoperoxidative and cytoprotective effects of apigenin, baicalein, kaempferol, luteolin and quercetin against doxorubic-ininduced oxidative stress were investigated in isolated rat heart cardiac myocytes, mitochondria and microsomes. After preincubation of cardiomyocytes with the test compounds for 1 It the cardiomyocytes were treated with the toxic agent, doxorubicin (100 muM for 8 h). Cardiomyocyte protection was assessed by extracellular LDH and cellular ADP and ATP production. Cytoprotection was concentration dependent for baicalein > luteolin congruent to apigenin > quercetin > kaempferol. All test compounds had significantly better protective effects than dexrazoxan, an agent currently used for adjuvant therapy during anthracycline antibiotic therapy. In microsomes/ mitochondria the IC50 values of lipid peroxidation inhibition for quercetin, baicalein, kaempferol, luteolin, and apigenin were 3.1 +/- 0.2/8.2 +/- 0.6, 3.3 +/- 0.3/9.6 +/- 0.5, 3.9 +/- 0.3/10.1 +/- 0.8, 22.9 +/- 1.7/18.2 +/- 0.7, and 338.8 +/- 23.1/ 73.1 +/- 6.4 muM, respectively. The antilipoperoxidative activity of apigenin differed from its cytoprotective effects, but correlated with the free radical scavenging of 2,2-diphenyl-1-picrylhydrazyl radical and half peak oxidation potential (E-p/2). Apigenin was the least effective of the flavonoids studied in all models except the cardiomyocyte model where its cardiomyocyte cytoprotective effect was comparable to other compounds. Copyright (C) 2004 John Wiley Sons, Ltd.